10x Genomics, Inc.TXGNASDAQ

Revenue (LTM)

$643M

+5.2% YoY

Net Income (LTM)

$-44M

+76.2% YoY

Free Cash Flow

$130M

Revenue CAGR (5Y)

+16.6%

Marginsdeclining

FCFTurned positive

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	490	516↑5.3%	619↑19.8%	611↓1.3%	643↑5.2%
Gross Profit	416	396↓4.9%	409↑3.4%	414↑1.3%	444↑7.1%
Operating Income	-53	-168↓217.4%	-265↓58.0%	-195↑26.7%	-111↑43.0%
Net Income	-58	-166↓185.1%	-255↓53.7%	-183↑28.4%	-44↑76.2%
EBITDA	-25	-128↓422.4%	-205↓59.6%	-134↑34.7%	-111↑17.2%
EPS Diluted	-0.53	-1.46↓175.5%	-2.18↓49.3%	-1.52↑30.3%	-0.35↑77.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	587	220↓62.6%	359↑63.5%	344↓4.2%	474↑37.8%
Total Current Assets	748	635↓15.1%	596↓6.1%	584↓2.0%	684↑17.1%
Total Assets	1,019	1,029↑1.0%	965↓6.2%	919↓4.8%	1,041↑13.4%
Total Current Liabilities	110	131↑18.7%	127↓2.9%	118↓7.5%	153↑30.5%
Total Liabilities	201	223↑10.9%	224↑0.4%	209↓7.0%	245↑17.5%
Total Equity	818	806↓1.4%	741↓8.0%	710↓4.2%	796↑12.1%
Total Debt	82	95↑16.1%	95↑0.2%	83↓13.4%	158↑90.9%
Net Debt	-505	-125↑75.4%	-264↓111.9%	-261↑0.9%	-316↓21.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-21	-34↓57.2%	-15↑54.8%	7↑143.9%	136↑1941.6%
Capital Expenditure	-101	-132↓30.0%	-50↑62.4%	-12↑75.0%	-6↑52.1%
Free Cash Flow	-123	-165↓34.7%	-65↑60.8%	-6↑91.1%	130↑2371.2%
Stock-Based Comp	96	137↑42.6%	167↑22.0%	141↓15.7%	109↓22.5%
Net Change in Cash	-93	-369↓298.3%	132↑135.8%	-15↓111.5%	130↑953.6%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance